Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Mattia Rosso, Shrishti Saxena & Tanuja Chitnis. (2020) Targeting IL-6 receptor in the treatment of neuromyelitis optica spectrum: a review of emerging treatment options. Expert Review of Neurotherapeutics 20:5, pages 509-516.
Read now
Read now
Lukmanee Tradtrantip, Nithi Asavapanumas & Alan S. Verkman. (2020) Emerging therapeutic targets for neuromyelitis optica spectrum disorder. Expert Opinion on Therapeutic Targets 24:3, pages 219-229.
Read now
Read now
Articles from other publishers (31)
Nicholas Schwab & Heinz Wiendl. (2023) Learning CNS immunopathology from therapeutic interventions. Science Translational Medicine 15:721.
Crossref
Crossref
Heather Y. F. Yong & Jodie M. Burton. (2023) A Clinical Approach to Existing and Emerging Therapeutics in Neuromyelitis Optica Spectrum Disorder. Current Neurology and Neuroscience Reports.
Crossref
Crossref
Wenqin Luo, Xiaofei Wang, Lingyao Kong, Hongxi Chen, Ziyan Shi & Hongyu Zhou. (2023) Initial BMI effects on clinical presentation and prognosis in neuromyelitis optica spectrum disorder. Annals of Clinical and Translational Neurology.
Crossref
Crossref
O. Mirmosayyeb, E.M. Ghaffary, S. Vaheb, R. Pourkazemi & V. Shaygannejad. (2023) Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) following COVID-19 vaccines: A systematic review. Revue Neurologique 179:4, pages 265-281.
Crossref
Crossref
Takashi Yamamura, Brian Weinshenker, Michael R. Yeaman, Jerome De Seze, Francesco Patti, Patricia Lobo, H.-Christian von Büdingen, Xiujing Kou, Kristina Weber & Benjamin Greenberg. (2022) Long-term safety of satralizumab in neuromyelitis optica spectrum disorder (NMOSD) from SAkuraSky and SAkuraStar. Multiple Sclerosis and Related Disorders 66, pages 104025.
Crossref
Crossref
John Souter, Mandana Behbahani, Shelly Sharma, Donald Cantrell & Tord D. Alden. (2022) Middle meningeal artery embolization in pediatric patient. Child's Nervous System.
Crossref
Crossref
Ruo-Yi Guo, Lu Zhang, Xuan Wang, Bo-Wen Yin, Shuang Song, Zhen Jia, Li Guo & Bin Li. (2022) LncRNA Xist may regulate Th17 cell differentiation through TDP43-IRF3 pathway in neuromyelitis optica spectrum disorders. Medical Hypotheses 165, pages 110894.
Crossref
Crossref
Mingchao Shi, Fengna Chu, Tao Jin & Jie Zhu. (2022) Progress in treatment of neuromyelitis optica spectrum disorders (NMOSD): Novel insights into therapeutic possibilities in NMOSD. CNS Neuroscience & Therapeutics 28:7, pages 981-991.
Crossref
Crossref
Madison MacDougall, Jad El-Hajj Sleiman, Philippe Beauchemin & Manu Rangachari. (2022) SARS-CoV-2 and Multiple Sclerosis: Potential for Disease Exacerbation. Frontiers in Immunology 13.
Crossref
Crossref
Vyanka Redenbaugh & Eoin P. Flanagan. (2022) Monoclonal Antibody Therapies Beyond Complement for NMOSD and MOGAD. Neurotherapeutics 19:3, pages 808-822.
Crossref
Crossref
Abdorreza Naser Moghadasi & Nasim Rezaeimanesh. 2022. Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases. Role of Microorganisms in Pathogenesis and Management of Autoimmune Diseases
195
210
.
Cristina Valencia-Sanchez & Eoin P. Flanagan. (2021) Uncommon inflammatory/immune-related myelopathies. Journal of Neuroimmunology 361, pages 577750.
Crossref
Crossref
Haixia Li, Shan Liu, Jinming Han, Shengxian Li, Xiaoyan Gao, Meng Wang, Jie Zhu & Tao Jin. (2021) Role of Toll-Like Receptors in Neuroimmune Diseases: Therapeutic Targets and Problems. Frontiers in Immunology 12.
Crossref
Crossref
Yanli Gao, Baoqi Zhang & Junyi Yang. (2020) Satralizumab for the Treatment of Neuromyelitis Optica Spectrum Disorders. Annals of Pharmacotherapy 55:9, pages 1167-1171.
Crossref
Crossref
Jie Lin, Binbin Xue, Ruofan Zhu, Juyuan Pan, Jia Li, Yan Lin, Xiang Li & Junhui Xia. (2021) Intravenous immunoglobulin as the rescue treatment in NMOSD patients. Neurological Sciences 42:9, pages 3857-3863.
Crossref
Crossref
Karina Maciak, Sylwia Pietrasik, Angela Dziedzic, Justyna Redlicka, Joanna Saluk-Bijak, Michał Bijak, Tomasz Włodarczyk & Elzbieta Miller. (2021) Th17-Related Cytokines as Potential Discriminatory Markers between Neuromyelitis Optica (Devic’s Disease) and Multiple Sclerosis—A Review. International Journal of Molecular Sciences 22:16, pages 8946.
Crossref
Crossref
Haoxiao Chang, Hengri Cong, Huabing Wang, Li Du, De-Cai Tian, Yuetao Ma, Yun Xu, Yupeng Wang, Linlin Yin & Xinghu Zhang. (2021) Thymic Involution and Altered Naive CD4 T Cell Homeostasis in Neuromyelitis Optica Spectrum Disorder. Frontiers in Immunology 12.
Crossref
Crossref
Roberto A. Cruz, Sana Chaudhary, Myriam Guevara & Ethan Meltzer. (2021) Neuromyelitis Optica Spectrum Disorders (NMOSD) and Connective Tissue Disease (CTD): an Update for the Rheumatologist. Current Rheumatology Reports 23:6.
Crossref
Crossref
Soniza Vieira Alves-Leon, Cristina dos Santos Ferreira, Alice Laschuk Herlinger, Fabricia Lima Fontes-Dantas, Fernanda Cristina Rueda-Lopes, Ronaldo da Silva FranciscoJr.Jr., João Paulo da Costa Gonçalves, Amanda Dutra de Araújo, Cláudia Cecília da Silva Rêgo, Luiza Mendonça Higa, Alexandra Lehmkuhl Gerber, Ana Paula de Campos Guimarães, Mariane Talon de Menezes, Marcelo Calado de Paula Tôrres, Richard Araújo Maia, Bruno Miceli Gonzalez Nogueira, Laise Carolina França, Marcos Martins da Silva, Christian Naurath, Aline Saraiva da Silva Correia, Claudia Cristina Ferreira Vasconcelos, Amilcar Tanuri, Orlando Costa FerreiraJr.Jr., Cynthia Chester Cardoso, Renato Santana Aguiar & Ana Tereza Ribeiro de Vasconcelos. (2021) Exome-Wide Search for Genes Associated With Central Nervous System Inflammatory Demyelinating Diseases Following CHIKV Infection: The Tip of the Iceberg. Frontiers in Genetics 12.
Crossref
Crossref
Elsa How Shing Koy, Pierre Labauge, Athan Baillet, Clément Prati, Hubert Marotte & Yves-Marie Pers. (2021) Immunomodulation with IL-17 and TNF-α in spondyloarthritis: focus on the eye and the central nervous system. Therapeutic Advances in Musculoskeletal Disease 13, pages 1759720X2110258.
Crossref
Crossref
Cristina Valencia-Sanchez & Dean M. Wingerchuk. (2020) Emerging Targeted Therapies for Neuromyelitis Optica Spectrum Disorders. BioDrugs 35:1, pages 7-17.
Crossref
Crossref
Pooja Ramakrishnan. (2020) Could Galectin-3 be a key player in the etiology of neuromyelitis optica spectrum disorder?. Medical Hypotheses, pages 110450.
Crossref
Crossref
Trygve Holmøy, Rune Alexander Høglund, Zsolt Illes, Kjell-Morten Myhr & Øivind Torkildsen. (2020) Recent progress in maintenance treatment of neuromyelitis optica spectrum disorder. Journal of Neurology.
Crossref
Crossref
Anthony Traboulsee, Benjamin M Greenberg, Jeffrey L Bennett, Lech Szczechowski, Edward Fox, Svitlana Shkrobot, Takashi Yamamura, Yusuke Terada, Yuichi Kawata, Padraig Wright, Athos Gianella-Borradori, Hideki Garren & Brian G Weinshenker. (2020) Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial. The Lancet Neurology 19:5, pages 402-412.
Crossref
Crossref
Takashi YamamuraIngo KleiterKazuo FujiharaJacqueline PalaceBenjamin GreenbergBeata Zakrzewska-PniewskaFrancesco PattiChing-Piao TsaiAlbert SaizHayato YamazakiYuichi KawataPadraig WrightJerome De Seze. (2019) Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder. New England Journal of Medicine 381:22, pages 2114-2124.
Crossref
Crossref
Aleida S.O. Dias, Priscila M. Sacramento, Lana Márcia Lopes, Marisa C. Sales, Camilla Castro, Ana Carolina R.A. Araújo, Alice M.M. Ornelas, Renato S. Aguiar, Renato Geraldo Silva-Filho, Regina Alvarenga & Cleonice A.M. Bento. (2019) TLR-2 and TLR-4 agonists favor expansion of CD4+ T cell subsets implicated in the severity of neuromyelitis optica spectrum disorders. Multiple Sclerosis and Related Disorders 34, pages 66-76.
Crossref
Crossref
Zhaoqi Yan, Wei Yang, Luke Parkitny, Sara A. Gibson, Kevin S. Lee, Forrest Collins, Jessy S. Deshane, Wayne Cheng, Amy S. Weinmann, Hairong Wei, Hongwei Qin & Etty N. Benveniste. (2019) Deficiency of Socs3 leads to brain-targeted experimental autoimmune encephalomyelitis via enhanced neutrophil activation and ROS production. JCI Insight 4:9.
Crossref
Crossref
Parya Alidadiani, Nahid Eskandari, Vahid Shaygannejad, Arezou Dabiri, Mostafa Manian, Hamidreza Jahanbani-Ardakani & Omid Mirmosayyeb. (2019) Expression of OX40 Gene and its Serum Levels in Neuromyelitis Optica Patients. Biomolecular Concepts 10:1, pages 62-67.
Crossref
Crossref
Jie Lin, Binbin Xue, Jia Li, Huaqing Xu, Xiaming Huang, Zhichao Yao, Xiang Li & Junhui Xia. (2017) Neutrophil to lymphocyte ratio may be a helpful marker to evaluate disease activity in NMOSD. Neurological Sciences 38:10, pages 1859-1863.
Crossref
Crossref
Priscila O. Barros, Aleida S.O. Dias, Taissa M. Kasahara, Alice M.M. Ornelas, Renato S. Aguiar, Soniza A. Leon, Anne Ruiz, Romain Marignier, Ana Carolina R.A. Araújo, Regina Alvarenga & Cleonice A.M. Bento. (2017) Expansion of IL-6+ Th17-like cells expressing TLRs correlates with microbial translocation and neurological disabilities in NMOSD patients. Journal of Neuroimmunology 307, pages 82-90.
Crossref
Crossref
Bin Liu, Wei Gao, Li Zhang, Jing Wang, Min Chen, Mingli Peng, Hong Ren & Peng Hu. (2017) Th17/Treg imbalance and increased interleukin-21 are associated with liver injury in patients with chronic severe hepatitis B. International Immunopharmacology 46, pages 48-55.
Crossref
Crossref